Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

NCT03976076

A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients.

Refractory Infantile Spasms

Bio-Pharm Solutions Co., Ltd.16 participantsStarted Apr 2020

Little Rock, Arkansas, United States • Los Angeles, California, United States • Los Angeles, California, United States +20 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients